Carl Schmid presents at National Association of Insurance Commissioners, along with other consumer representatives, on discrimination in insurance benefit design with a focus on prescription drugs and adverse tiering.
Role of PBMs in patient access & affordability of prescription drugs & potential solutions
HIV+Hep’s Carl Schmid, a consumer representative to the National Association of Insurance Commissioners (NAIC), presents to the NAIC PBM subgroup, along with ACSCAN’s Anna Howard, on how PBM’s impact patient access and affordability of prescription drugs.
Impact of PBM practices on patients
Discusses how Pharmacy Benefits Managers impact drug formulary decisions, patient cost sharing, utilization management, and pharmacy access.
Copay Accumulators, State Bans & IRS Issues
HIV+Hep’s Carl Schmid’s presentation before the NAIC Regulatory Framework Task Force on the value of copay assistance for Rx, state laws that ensure copay assistance counts, and ways to mitigate any potential conflicts with those state laws with IRS/Health Savings Account issues.
Policies and programs needed to ensure PrEP access nationwide
Details the policies and programs needed to overcome barriers to #PrEP access, including funding a national PrEP program with grants for community and provider outreach, coverage of associated services, and enforcing no-cost-sharing rules